Her 2 and topoisomerase (TOPO)IIα as predictive markers for node-positive (N+) breast cancer (BC) patients (PTS) randomised to adjuvant CMF or epirubicin (E) — cyclophosphamide (C)
EUROPEAN JOURNAL OF CANCER（1999）
关键词
breast cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要